Who are OligoG Dry powder for inhalation's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oligog-dry-powder-for-inhalation.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

OligoG Dry powder for inhalation — Competitive Intelligence Brief

OligoG Dry powder for inhalation (OligoG Dry powder for inhalation) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anti-biofilm agent; inhaled oligosaccharide therapeutic. Area: Infectious Disease.

discontinued Anti-biofilm agent; inhaled oligosaccharide therapeutic Bacterial biofilm matrix and adhesion mechanisms in cystic fibrosis airways Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

OligoG Dry powder for inhalation (OligoG Dry powder for inhalation) — AlgiPharma AS. OligoG is an inhaled oligosaccharide that disrupts bacterial biofilm formation and reduces pathogenic adherence in cystic fibrosis airways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
OligoG Dry powder for inhalation TARGET	OligoG Dry powder for inhalation	AlgiPharma AS	discontinued	Anti-biofilm agent; inhaled oligosaccharide therapeutic	Bacterial biofilm matrix and adhesion mechanisms in cystic fibrosis airways

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anti-biofilm agent; inhaled oligosaccharide therapeutic class)

AlgiPharma AS · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). OligoG Dry powder for inhalation — Competitive Intelligence Brief. https://druglandscape.com/ci/oligog-dry-powder-for-inhalation. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab